HTLV seroepidemiology in a central African population with high incidence of tropical spastic paraparesis
✍ Scribed by P. Goubau; H. Carton; K. Kazadi; K.W. Muya; J. Desmyter
- Publisher
- Elsevier Science
- Year
- 1990
- Tongue
- English
- Weight
- 252 KB
- Volume
- 84
- Category
- Article
- ISSN
- 0035-9203
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The oncoprotein Tax was characterized genetically from a large cohort of human T‐cell lymphotropic virus type 1 (HTLV‐1) seropositive individuals from the most endemic region of HTLV‐1‐associated myelopathy/tropical spastic paraparesis (HAM/TSP) and HTLV‐1 infection in Argentina, the pr
## Abstract The human T‐cell lymphotropic virus type 1 (HTLV‐1) is the etiological agent of HTLV‐1‐associated myelopathy/tropical spastic paraparesis (HAM/TSP), a progressive disease causing paraparesis of the lower limbs. Only a minority of persons infected with HTLV‐1 develop HAM/TSP. Universal s
## Abstract Human T‐lymphotropic virus 1 (HTLV‐1) infection is associated with HTLV‐associated myelopathy/tropical spastic paraparesis (HAM/TSP), which affects approximately 5% of carriers. High proviral load is a risk marker for HAM/TSP, although there is an overlap of proviral load levels in peri